Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Xiang

Showing results (551-560 of 578) with videos related to

Pageof 58
Sort By:
Carcinogenesis|May 25, 2019
TSC22D2 identified as a candidate susceptibility gene of multi-cancer pedigree using genome-wide linkage analysis and whole-exome sequencingLan Xiao, Fang Wei, Fang Liang, et al.
Plos One|May 8, 2013
LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathwaysYixin Yang, Qianjin Liao, Fang Wei, et al.
The FEBS Journal|August 28, 2014
SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cellsWenling Zhang, Zhaoyang Zeng, Fang Wei, et al.
Nature Communications|March 28, 2026
High-risk EBV promotes immune evasion in nasopharyngeal carcinoma by upregulating HLA-DP via the encoded BALF2-HR variantYi Meng, Qian Wang, Lei Shi, et al.
Oncogene|November 2, 2021
BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinomaXianjie Jiang, Xiangying Deng, Jie Wang, et al.
Cancer Letters|March 30, 2026
A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growthYao-Tsung Tsai, Min-Hsuan Yen, Ping-Jen Hu, et al.
Molecular Cancer|February 1, 2020
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapyDaixi Ren, Yuze Hua, Boyao Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 2020
EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1Yingfen Wu, Dan Wang, Fang Wei, et al.
Cell Death & Disease|September 2, 2016
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103Baoyu He, Weiming Li, Yingfen Wu, et al.
Cancer Research|July 29, 2021
Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1Junshang Ge, Jie Wang, Fang Xiong, et al.
Pageof 58

Showing results (551-560 of 578) with videos related to

Sort By:
Pageof 58
Carcinogenesis|May 25, 2019
TSC22D2 identified as a candidate susceptibility gene of multi-cancer pedigree using genome-wide linkage analysis and whole-exome sequencingLan Xiao, Fang Wei, Fang Liang, et al.
Plos One|May 8, 2013
LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathwaysYixin Yang, Qianjin Liao, Fang Wei, et al.
The FEBS Journal|August 28, 2014
SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cellsWenling Zhang, Zhaoyang Zeng, Fang Wei, et al.
Nature Communications|March 28, 2026
High-risk EBV promotes immune evasion in nasopharyngeal carcinoma by upregulating HLA-DP via the encoded BALF2-HR variantYi Meng, Qian Wang, Lei Shi, et al.
Oncogene|November 2, 2021
BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinomaXianjie Jiang, Xiangying Deng, Jie Wang, et al.
Cancer Letters|March 30, 2026
A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growthYao-Tsung Tsai, Min-Hsuan Yen, Ping-Jen Hu, et al.
Molecular Cancer|February 1, 2020
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapyDaixi Ren, Yuze Hua, Boyao Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 2020
EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1Yingfen Wu, Dan Wang, Fang Wei, et al.
Cell Death & Disease|September 2, 2016
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103Baoyu He, Weiming Li, Yingfen Wu, et al.
Cancer Research|July 29, 2021
Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1Junshang Ge, Jie Wang, Fang Xiong, et al.
Pageof 58